The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
Hertzel C. Gerstein, Robert G. Hart, Helen M. Colhoun, Rafael Díaz, Mark Lakshmanan, Fady T. Botros, Jeffrey L. Probstfield, Matthew C. Riddle, Lars Rydén, Charles Atisso, Leanne Dyal, Stephanie Hall, Álvaro Avezum, Jan Basile, Ignacio Conget, William C. Cushman, Nicolae Hâncu, M Hanefeld, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev
Topics & Concepts
DulaglutideMedicinePlaceboStroke (engine)Modified Rankin ScaleRandomized controlled trialInternal medicineDiabetes mellitusClinical trialType 2 diabetesPhysical therapyExenatideIschemic strokeEndocrinologyAlternative medicinePathologyEngineeringIschemiaMechanical engineeringDiabetes Treatment and ManagementMedication Adherence and ComplianceAntiplatelet Therapy and Cardiovascular Diseases